Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05812859 · ClinicalTrials.gov registry record · NA
Vaginal Orthosis Use After Vaginal Reconstructive Surgery
A NA study of Pelvic Organ Prolapse, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05812859 is a NA study of Pelvic Organ Prolapse that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05812859, a NA study of Pelvic Organ Prolapse, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
A novel vaginal orthosis, or splint, made of silicone will be used daily to help support the healing vaginal reconstruction during the post-operative phase from week 2 to week 12.
Conditions Studied
Interventions
- DEVICE Vaginal Orthosis (COSM Medical)
Study Locations (1)
Alabama
- UAB Hospital - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-01-29 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05812859
The ClinicalTrials.gov registry entry for NCT05812859 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (79% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 1 intervention - of which Vaginal Orthosis (COSM Medical) is the first listed.
NCT05812859 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT05812859 about?
NCT05812859 is a clinical study titled "Vaginal Orthosis Use After Vaginal Reconstructive Surgery". A novel vaginal orthosis, or splint, made of silicone will be used daily to help support the healing vaginal reconstruction during the post-operative phase from week 2 to week 12.
What is the current status of trial NCT05812859?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-01-29. Estimated completion is 2026-07.
What conditions does trial NCT05812859 study?
This clinical trial studies the following conditions: Pelvic Organ Prolapse.
What interventions are being tested in trial NCT05812859?
The interventions under investigation include: Vaginal Orthosis (COSM Medical) (DEVICE).
Who is sponsoring clinical trial NCT05812859?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05812859 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Organ Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
RECRUITING · NA
-
Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy
RECRUITING · NA
-
The AccelERate Trial
RECRUITING · NA
-
Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.